Abstract:OBJECTIVEPulmonary hypertension (PH) is a common complication of congenital heart defects with a left-to-right shunt characterized by high pulmonary blood flow. Pulmonary vascular structural remodeling (PVSR) is the pathological basis of PH. However, the pathophysiologic features and mechanisms responsible for PH and PVSR induced by increased pulmonary blood flow have not been fully understood. The present study was designed to explore the possible effect and mechanism of hydrogen sulfide (H(2)S) on the regulation of PVSR induced by high pulmonary flow in rats.METHODSThirty-two male SD rats, weighing 120 - 140 g, were randomly divided into shunt group (n = 8), shunt + NaHS group (n = 8), control group (n = 8) and control + NaHS group (n = 8). Rats in shunt group and shunt + NaHS group were subjected to an abdominal aorta-inferior vena cava shunt to create an animal model of high pulmonary flow. Rats in the control and control + NaHS groups underwent the same experimental protocol as mentioned above except for the shunt procedure. Rats in the shunt + NaHS and control + NaHS groups were intraperitoneally injected with NaHS at 56 micromol/(kgxd), and rats in the shunt and control groups were injected with the same volume of physiological saline. After 11 weeks of experiment, rats were sacrificed and lung tissues were obtained. The percentage of muscularized artery (MA) was calculated. The changes in relative medial thickness (RMT) in small pulmonary arteries and median pulmonary arteries were examined. Proliferative cell nuclear antigen (PCNA), extracellular signal-regulated kinase (ERK1) and phosphorylation extracellular signal-regulated kinase (P-ERK1) protein expression were examined by Western blot, and at the same time, PCNA protein expression by pulmonary artery smooth muscle cells was observed by immunohistochemistry.RESULTSAfter 11 weeks of shunt, compared with control group, the percentage of MA increased significantly (25.12 +/- 2.26 vs 14.42 +/- 3.41, P < 0.05), and RMT in small pulmonary arteries and median pulmonary arteries increased significantly in rats of shunt group (23.6 +/- 3.5 vs 12.6 +/- 2.1, 24.8 +/- 1.9 vs 13.5 +/- 2.2, P < 0.05 for all). PCNA protein expression in small and median pulmonary arteries increased significantly (0.49 +/- 0.04 vs 0.39 +/- 0.07, 0.46 +/- 0.08 vs 0.36 +/- 0.05, P < 0.01 for all), and the ratio of PERK/ERK1 protein expression of pulmonary arteries increased significantly (P < 0.01) in rats of shunt group compared with those of control group. After the administration of exogenous H(2)S donor, NaHS, for 11 weeks, in contrast to rats in shunt group, the percentage of MA decreased significantly (21.5 +/- 2.0 vs 25.1 +/- 2.3, P < 0.05), and RMT in small and median pulmonary arteries decreased significantly (20.2 +/- 2.8 vs 23.6 +/- 3.5, 20.8 +/- 3.1 vs 20.8 +/- 3.1, P < 0.05 for all) in rats of shunt + NaHS group. PCNA protein expression in small and median pulmonary artery smooth muscle cells decreased significantly (0.32 +/- 0.06 vs 0.49 +/- 0.04, 0.29 +/- 0.07 vs 0.46 +/- 0.08, P < 0.01 for all), and the ratio of PERK/ERK1 protein expression of pulmonary arteries decreased significantly (P < 0.01) in rats of shunt + NaHS group compared with that of shunt group.CONCLUSIONH(2)S may play a regulatory role in pulmonary vascular structural remodeling induced by high pulmonary blood flow via mitogen-activated protein kinase (MAPK)/ERK signal transduction pathway.

Roles and Signal Pathways of Adrenomedullin and Adrenotensin in Pulmonary Remodeling Due to Left to Right Shunt in Rats

Roles and Signal Pathways of Adrenomedullin and Proadrenomedullin N-terminal 20 Peptide in Pulmonary Hypertension Due to High Pulmonary Blood Flow in Rat

Change of Different Active Peptide Fragments Derived from Proadrenomedullin in Pulmonary Hypertension Rats' Lung

Expression of Peptide Fragments from Proadm and Involvement of Mitogen-Activated Protein Kinase Signaling Pathways in Pulmonary Remodeling Induced by High Pulmonary Blood Flow

Alteration of mevalonate pathway related enzyme expressions in pressure overload-induced cardiac hypertrophy and associated heart failure with preserved ejection fraction.

[Alterations of Proadrenomedullin N-terminal 20-Peptide in Rats with Pulmonary Hypertension Induced by High Pulmonary Blood Flow].

Differentiation of Pulmonary Vascular Remodeling Pattern in 4 Models of Pulmonary Hypertension

Effect of Adrenomedullin on Proadrenomedullin N-terminal 20-Peptide and Hypoxic Pulmonary Vascular Structural Remodeling in Rats

Regulatory effect of adrenomedulin on pulmonary tissue oxidative stress in rats with pulmonary hypertension induced by high pulmonary blood flow

Chronic administration of adrenomedullin attenuates hypoxic pulmonary vascular structural remodeling and inhibits proadrenomedullin N-terminal 20-peptide production in rats.

[Expression of Adrenomedullin and Its Receptor in Lungs of Rats with Hypoxia-Induced Pulmonary Hypertension].

Alteration of proadrenomedullin N-terminal 20-peptide in rats with chronic hypoxic pulmonary hypertension

Sildenafil Up-Regulates Kv1.5 Mrna Expression in Rats with Pulmonary Hypertension

The role of RhoA/ROCK pathway in the rat models of left heart disease-associated pulmonary hypertension

[Effect of Adrenomedullin 1-50 on Chronic Hypoxic Pulmonary Hypertension in Rats].

[Mechanism by Which Hydrogen Sulfide Regulates Pulmonary Vascular Structural Remodeling Induced by High Pulmonary Blood Flow in Rats].

[Changes of Intermedin/adrenomedullin 2 and Its Receptors in the Right Ventricle of Rats with Chronic Hypoxic Pulmonary Hypertension].

Adrenomedullin Relieves the Pulmonary Hypertension in Hypoxic Rats

[Adrenomedullin Alleviates Collagen Accumulation in Pulmonary Arteries of Rats with Hypoxic Pulmonary Hypertension].

Impact of Hydrogen Sulfide Donor on Pulmonary Vascular Structure and Vasoactive Peptides in Rats with Pulmonary Hypertension Induced by High Pulmonary Blood Flow

DAN Plays Important Compensatory Roles in Systemic‐to‐pulmonary Shunt Associated Pulmonary Arterial Hypertension